Sensyne Algorithm For COVID-19 Risk Prediction Gets UK Regulatory Approval
Executive Summary
Sensyne obtained UK regulatory approval for its SYNE-COV machine learning algorithm to assess the long-term risks of COVID-19.
You may also be interested in...
Not All AI Companies Are A Success: The Woes Of Sensyne
The business founded by Lord Drayson has struggled to achieve commercial success for its artificial intelligence products.
First Test That Predicts Severe Outcomes In COVID-19 Patients Receives CE Mark
MeMed’s test measures immune system response to assess a patient’s COVID-19 trajectory.
Sensyne Partners With Excalibur To Improve Usability Of COVID-19 Tests
Sensyne has licensed its MagnifEye artificial intelligence technology to Excalibur Healthcare to improve the detection of COVID-19 infection at low viral loads.